Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Trinity Biotech Plc (TRIB) ADR Each Repr 4 Cls A Ord USD0.0109

Sell:$2.48 Buy:$2.49 Change: $0.18 (6.77%)
NASDAQ:2.13%
Market closed |  Prices as at close on 13 July 2020 | Switch to live prices |
Sell:$2.48
Buy:$2.49
Change: $0.18 (6.77%)
Deal now Deal for just £11.95 per trade in a Fund and Share Account
Market closed |  Prices as at close on 13 July 2020 | Switch to live prices |
Sell:$2.48
Buy:$2.49
Change: $0.18 (6.77%)
Market closed |  Prices as at close on 13 July 2020 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Trinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes, and disorders of the liver and intestine. It operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business. Trinity Biotech's blood bank screening business unit manufactures products to screen donated blood for transfusion-transmissible infections.

Contact details

Address:
Bray, Co Wicklow, Ireland
BRAY
18
Ireland
Telephone:
+353 (1) 2769800
Website:
https://www.trinitybiotech.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
TRIB
ISIN:
US8964383066
Market cap:
$63.95 million
Shares in issue:
96.16 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Ronan O'Caoimh
    Executive Chairman of the Board
  • Kevin Tansley
    Chief Financial Officer, Secretary
  • Rory Nealon
    Chief Operating Officer, Executive Director
  • Eric Brouwer
    Chief Scientific Officer, and Vice President Cardiac
  • James Walsh
    Executive Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a Fund and Share Account

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.